The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Jason A. Zell

Chao Family Comprehensive Cancer Center

University of California

Irvine

CA, 92697

USA

[email]@uci.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, CA, 92697, USA. 2012
  • Genetic Epidemiology Research Institute, Department of Epidemiology, University of California at Irvine, 92697, USA. 2007 - 2010
  • Division of Hematology/Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California at Irvine School of Medicine, USA. 2005 - 2009
  • Chao Family Comprehensive Cancer Center, Division of Hematology/Oncology, Genetic Epidemiology Research Institute, Department of Medicine, USA. 2006 - 2007

References

  1. Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas. Zell, J.A., Lin, B.S., Madson, N., McLaren, C.E., Gerner, E.W., Meyskens, F.L. Cancer. Causes. Control (2012) [Pubmed]
  2. Meat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study. Zell, J.A., Ziogas, A., Bernstein, L., Clarke, C.A., Deapen, D., Largent, J.A., Neuhausen, S.L., Stram, D.O., Ursin, G., Anton-Culver, H. Cancer. Prev. Res. (Phila) (2010) [Pubmed]
  3. Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients. Zell, J.A., McLaren, C.E., Chen, W.P., Thompson, P.A., Gerner, E.W., Meyskens, F.L. J. Natl. Cancer Inst. (2010) [Pubmed]
  4. Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis. Zell, J.A., Ziogas, A., Bernstein, L., Clarke, C.A., Deapen, D., Largent, J.A., Neuhausen, S.L., Stram, D.O., Ursin, G., Anton-Culver, H. Cancer (2009) [Pubmed]
  5. Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival. Zell, J.A., Ziogas, A., Ignatenko, N., Honda, J., Qu, N., Bobbs, A.S., Neuhausen, S.L., Gerner, E.W., Anton-Culver, H. Clin. Cancer Res. (2009) [Pubmed]
  6. Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas. Zell, J.A., Pelot, D., Chen, W.P., McLaren, C.E., Gerner, E.W., Meyskens, F.L. Cancer. Prev. Res. (Phila) (2009) [Pubmed]
  7. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry. Zell, J.A., Tsang, W.Y., Taylor, T.H., Mehta, R.S., Anton-Culver, H. Breast Cancer Res. (2009) [Pubmed]
  8. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules. Zell, J.A., Ou, S.H., Ziogas, A., Anton-Culver, H. Cancer (2008) [Pubmed]
  9. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. Zell, J.A., Cinar, P., Mobasher, M., Ziogas, A., Meyskens, F.L., Anton-Culver, H. J. Clin. Oncol. (2008) [Pubmed]
  10. Survival after colorectal cancer diagnosis is associated with colorectal cancer family history. Zell, J.A., Honda, J., Ziogas, A., Anton-Culver, H. Cancer Epidemiol. Biomarkers Prev. (2008) [Pubmed]
  11. Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry. Zell, J.A., Ignatius Ou, S.H., Ziogas, A., Anton-Culver, H. J. Thorac. Oncol (2007) [Pubmed]
  12. Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. Zell, J.A., Ignatenko, N.A., Yerushalmi, H.F., Ziogas, A., Besselsen, D.G., Gerner, E.W., Anton-Culver, H. Int. J. Cancer (2007) [Pubmed]
  13. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Zell, J.A., Rhee, J.M., Ziogas, A., Lipkin, S.M., Anton-Culver, H. Cancer Epidemiol. Biomarkers Prev. (2007) [Pubmed]
  14. Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease. Zell, J.A., McEligot, A.J., Ziogas, A., Holcombe, R.F., Anton-Culver, H. Nutr. Cancer (2007) [Pubmed]
  15. Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis. Zell, J.A., Ou, S.H., Ziogas, A., Anton-Culver, H. Ann. Oncol. (2006) [Pubmed]
  16. Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab. Zell, J.A., Yoon, E.J., Ignatius Ou, S.H., Hoefs, J.C., Chang, J.C. Anticancer. Drugs (2005) [Pubmed]
  17. Neoplastic fever: a neglected paraneoplastic syndrome. Zell, J.A., Chang, J.C. Support. Care. Cancer (2005) [Pubmed]
  18. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. Zell, J.A., Ou, S.H., Ziogas, A., Anton-Culver, H. J. Clin. Oncol. (2005) [Pubmed]
 
WikiGenes - Universities